Aptevo Therapeutics Inc.

APVO | NASDAQ

Price Alert Chart Builder DCF Calculator

$1.84

$0 (0.00%)

At close: Sep 21, 2026, 3:59 PM ET

$1.81

-$0.03 (-1.63%)

After-hours: Sep 21, 2026, 7:30 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

+0.00%

(1D)

Rating

Updated: Aug 26, 2026

Fundamentals Weak

Market Sentiment Neutral

Moat None

Full Analysis

Key Statistics

Market Data

Market Cap $4.02M

1D Range

1.80 1.88

52W Range

1.37 35.64

Valuation (TTM)

PE -0.01

PB 0.67

EV/EBITDA 0.06

Valuation (NTM)

Forward PE N/A

Forward PEG 0.00

Price Target N/A

Cash Flow

FCF Yield -629.8%

SBC Adj. FCF Yield -634.6%

SBC Impact -0.8%

Margins

Gross Margin 0.0%

Operating Margin 0.0%

FCF Margin N/A

Growth (CAGR)

Revenue 3Y | 5Y N/A | -100.0%

Dil EPS 3Y | 5Y 147.6% | 7.4%

FCF 3Y | 5Y -2.1% | -13.0%

Returns

ROA -181.9%

ROE -201.5%

ROIC -262.3%

Financial Health

Net Cash

$5.59M

Current Ratio 2.08

Interest Coverage 0.00

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

Aptevo Therapeutics Inc. is a clinical-stage biotechnology company primarily focused on pioneering immunotherapeutic agents for a variety of cancer treatments across the United States. Its foremost in...

Sector Healthcare

Industry Biotechnology

Employees 33

IPO Date Jul 19, 2016

Website www.aptevotherapeutics.com

Fiscal Year January - December

Full Company Profile

Latest News

No news articles available yet.